ORIC Pharmaceuticals, Inc. (ORIC)
USD 7.68
(-6.91%)
USD 7.68
(-6.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 1.03 Million | 966 Thousand | 897 Thousand | 970 Thousand | 1 Million | 900 Thousand |
| Gross Profit | -1.03 Million | -966 Thousand | -897 Thousand | -970 Thousand | -1 Million | -900 Thousand |
| Operating Expenses | 110.78 Million | 86.76 Million | 78.87 Million | 49.34 Million | 28.56 Million | 22.37 Million |
| Selling, General and Administrative Expenses | 25.6 Million | 25.08 Million | 22.01 Million | 13.42 Million | 5.72 Million | 3.34 Million |
| Research and Development Expenses | 85.17 Million | 61.68 Million | 56.85 Million | 35.92 Million | 22.84 Million | 19.02 Million |
| Other Expenses | - | 5 Million | 15 Thousand | 177 Thousand | 289 Thousand | 233 Thousand |
| Cost and Expenses | 110.78 Million | 86.76 Million | 78.87 Million | 49.34 Million | 28.56 Million | 22.37 Million |
| Operating Income | -110.78 Million | -91.76 Million | -78.87 Million | -74.18 Million | -28.56 Million | -22.37 Million |
| Interest Expense | - | 2.64 Million | - | - | - | - |
| Income Tax Expense | - | 2.35 Million | -1.03 Million | 23.56 Million | -1.39 Million | -1 Million |
| Earnings before Tax | -100.69 Million | -89.12 Million | -78.71 Million | -73.7 Million | -26.88 Million | -21.36 Million |
| Net Income | -100.69 Million | -91.47 Million | -77.67 Million | -97.27 Million | -25.48 Million | -21.36 Million |
| Earnings Per Share Basic | -1.96 | -2.31 | -2.05 | -4.43 | -0.85 | -1.12 |
| Earnings Per Share Diluted | -1.96 | -2.31 | -2.05 | -4.43 | -0.85 | -1.12 |
| Weighted Average Shares Outstanding | 51.45 Million | 39.65 Million | 37.95 Million | 21.94 Million | 29.9 Million | 19.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.45 Million | 39.65 Million | 37.95 Million | 21.94 Million | 29.9 Million | 19.14 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -109.74 Million | -91.76 Million | -77.97 Million | -74.18 Million | -27.54 Million | -20.46 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.53 Million | - | - | - |
| Cost of Revenue | 272 Thousand | 261 Thousand | 263 Thousand | 1.03 Million | 257 Thousand | 259 Thousand |
| Gross Profit | -272 Thousand | -261 Thousand | 1.27 Million | -1.03 Million | -257 Thousand | -259 Thousand |
| Operating Expenses | 36.01 Million | 28.72 Million | 31.16 Million | 109.74 Million | 28.68 Million | 24.99 Million |
| Selling, General and Administrative Expenses | 7.07 Million | 6.76 Million | 6.68 Million | - | 6.29 Million | 6.2 Million |
| Research and Development Expenses | 28.94 Million | 21.96 Million | 24.48 Million | - | 22.38 Million | 18.78 Million |
| Other Expenses | 4.05 Million | 3.97 Million | 3.09 Million | - | 3.2 Million | 2.04 Million |
| Cost and Expenses | 36.01 Million | 28.99 Million | 31.42 Million | 110.78 Million | 28.68 Million | 24.99 Million |
| Operating Income | -36.01 Million | -28.99 Million | -31.42 Million | -110.78 Million | -28.68 Million | -24.99 Million |
| Interest Expense | - | - | 1.98 Million | - | - | - |
| Income Tax Expense | -272 Thousand | 217.72 Thousand | 2.24 Million | - | -257 Thousand | 136.91 Thousand |
| Earnings before Tax | -31.96 Million | -25.01 Million | -28.33 Million | -100.69 Million | -25.47 Million | -22.94 Million |
| Net Income | -31.96 Million | -25.01 Million | -28.33 Million | -100.69 Million | -25.47 Million | -22.94 Million |
| Earnings Per Share Basic | -0.45 | -0.37 | -0.49 | - | -0.44 | -0.50 |
| Earnings Per Share Diluted | -0.45 | -0.37 | -0.49 | - | -0.44 | -0.50 |
| Weighted Average Shares Outstanding | 70.34 Million | 67.34 Million | 57.46 Million | 51.45 Million | 57.4 Million | 45.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 70.34 Million | 67.34 Million | 57.46 Million | 51.45 Million | 57.4 Million | 45.65 Million |
| Gross Margin | - | - | 0.83 | - | - | - |
| EBIT Margin | - | - | -20.26 | - | - | - |
| Profit Margin | - | - | -18.42 | - | - | - |
| EBITDA | -36.01 Million | -28.72 Million | -31.16 Million | - | -28.68 Million | -24.73 Million |
| Earnings Before Tax Margin | - | - | -20.43 | - | - | - |
029960
DGGXF
LACTOSE
PSO
CSLI
VLHZ